Abstract
Cancer is the second most common cause of death in women of reproductive age, with the incidence of cancer in pregnancy ranging from 0.07 to 0.1% [1]. As cancer therapy is becoming more efficacious and women are waiting later to begin childbearing, cancer in pregnancy as well as pregnancy in cancer survivors are both increasing in prevalence. With the increasing survival of cancer patients, issues regarding the quality of life in cancer survivors are becoming progressively more important. Unfortunately, many of the successful treatment options for cancer lead to infertility. In a time of tragedy, while facing the new diagnosis of cancer, it is very difficult for patients to think about the implications of their therapies. As a healthcare provider, one must weigh a variety of considerations in such circumstances including but not limited to the clinical, biological, ethical, legal and psychosocial issues surrounding cancer and pregnancy.
My partner and I agreed we wanted a big family so as soon as we agreed we were going to be a couple we wanted to get started on that family. I was thrilled when I got pregnant right away and relieved that the morning sickness wasn’t too bad. Except for the odd looking mole I had developed on my growing belly, I felt great and people told me I looked healthy. My OB/GYN said the mole was probably nothing but suggested I see a dermatologist. I made the appointment more out of vanity than real concern and so it didn’t occur to me to bring anyone with me to the dermatologist. My partner and my sister had come to every OB/GYN apt with me but I thought I was going to just run in for a quick appointment and the doctor would tell me this mole would go away after pregnancy. But, it didn’t happen that way. I was by myself when the dermatologist told me she was concerned and suspected melanoma. My head was spinning as I thought about who to call first – my sister? My partner? My OB-GYN? A priest? So I just sat there in the office not calling anyone and rationalized to myself that everything was fine and there must be a mistake. Hours later I was on the Internet trying to find out what the odds were of getting cancer while pregnant. Whatever those odds were, they had found me. A week later it was confirmed – I had advanced melanoma and I was 5 months pregnant.
I was told I could have surgery right away with no harm to my baby, but the additional treatment I was likely to need could not be administered safely while I was pregnant. My doctor said my chances of long-term survival would be significantly improved if I had chemo right away, but I couldn’t do it while I was pregnant. My sister said she just wanted me alive – whatever it took. My partner said he didn’t even see what the quandary was because if I didn’t survive there would be no baby and no mother to raise the baby.
I wanted this baby as much as I wanted to live, and I didn’t want one more or less than the other. I asked my sister if she would promise to raise this baby if anything happened to me and although she said she couldn’t bear to think about it, she agreed. That was the tipping point for me. I decided to eschew the medical advice and go on with the pregnancy and delay treatment.
My son was born healthy 3 months later although I eventually agreed to an early inducement so I could begin treatment. My partner thought I was crazy and ended our relationship but I am hopeful he will continue to see his son. I have good days and bad days now. The treatment has been exhausting and my oncologist says he is not seeing the progress he had hoped. I don’t regret my decision. Today my son took his first steps and that was such a joy to witness. Will I be here to see him run or go to school or learn to drive? I don’t know, and really none of us knows. I may die tomorrow from cancer and you may die in a car accident. What matters is today and for today, my son smiling and laughing and learning how to walk. I just take it one day at a time.
Debbie, Adult Cancer Patient
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pavlidis N (2002) Coexistence of Pregnancy and Malignancy. Oncologist 7(4):279–287
Speroff L, Fritz MA (2005) Clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins. Available from: http://www.loc.gov/catdir/enhancements/fy0712/2004048582-d.html. Materials specified: Publisher description http://www.loc.gov/catdir/enhancements/fy0712/2004048582-d.html. Philadelphia, Pennsylvania
Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE (2010) Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health 55(2):175–180
Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, American OK (2006) Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917–2931
Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, Wilson C, Munster P (2007) Discussion of fertility preservation with newly diagnosed patients: oncologists’ views. J Cancer Surviv 1(2):146–155
Quinn GP, Vadaparampil ST (2009) Fertility preservation and adolescent/young adult cancer patients: physician communication challenges. J Adolesc Health 44(4):394–400
Quinn GP, Vadaparampil ST, King L, Miree CA, Wilson C, Raj O, Watson J, Lopez A, Albrecht TL (2009) Impact of physicians’ personal discomfort and patient prognosis on discussion of fertility preservation with young cancer patients. Patient Educ Couns 77(3):338–343
Thompson SC, Nanni C, Schwankovsky L (1990) Patient-oriented interventions to improve communication in a medical office visit. Health Psychol 9(4):390–404
Yap JK, Davies M (2007) Fertility preservation in female cancer survivors. J Obstet Gynaecol 27(4):390–400
Maltaris T, Beckmann MW, Dittrich R (2009) Review. Fertility preservation for young female cancer patients. In Vivo 23(1):123–130
Mok CC, Lau CS, Wong RW (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41(5):831–837
Warne GL, Fairley KF, Hobbs JB, Martin FI (1973) Cyclophosphamide-induced ovarian failure. N Engl J Med 289(22):1159–1162
Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG (2001) Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 16(4):632–637
Dowsett M, Richner J (1991) Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients. Oncology 48(3):215–220
Mehta RR, Beattie CW, Das Gupta TK (1992) Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 20(2):125–132
Sonmezer M, Oktay K (2004) Fertility preservation in female patients. Hum Reprod Update 10(3):251–266
Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ (1997) Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod 12(11):2483–2488
Meirow D, Nugent D (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7(6):535–543
Wallace WH, Thomson AB, Saran F, Kelsey TW (2005) Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62(3):738–744
Lushbaugh CC, Casarett GW (1976) The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 37(2 Suppl):1111–1125
Critchley HO, Wallace WH (2005) Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 34:64–68
Fenig E, Mishaeli M, Kalish Y, Lishner M (2001) Pregnancy and radiation. Cancer Treat Rev 27(1):1–7
Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328(2):87–94
Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA (1981) Female reproductive potential after treatment for Hodgkin’s disease. N Engl J Med 304(23):1377–1382
Sutton R, Buzdar AU, Hortobagyi GN (1990) Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 65(4):847–850
Chatterjee R, Goldstone AH (1996) Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 17(1):5–11
Chatterjee R, Kottaridis PD (2002) Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplant 30(10):629–635
Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718–1729
Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA (1989) Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 17(5):409–413
Wallace WH, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR (1989) Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol 62(743):995–998
Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17(9):2670–2675
Tangir J, Zelterman D, Ma W, Schwartz PE (2003) Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 101(2):251–257
Meirow D (1999) Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 33(1–2):65–76
Blumenfeld Z, Haim N (1997) Prevention of gonadal damage during cytotoxic therapy. Ann Med 29(3):199–206
Meirow D (2000) Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 169(1–2):123–131
Martin JR, Kodaman P, Oktay K, Taylor HS (2007) Ovarian cryopreservation with transposition of a contralateral ovary: a combined approach for fertility preservation in women receiving pelvic radiation. Fertil Steril 87(1):189 e5–e7
Woodruff TK, Snyder KA (2007) Oncofertility: fertility preservation for cancer survivors. Springer, New York, NY
Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH (2003) Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod 18(1):137–139
Georgescu ES, Goldberg JM, du Plessis SS, Agarwal A (2008) Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv 63(11):725–732
Gao S, Li Y, Gao X, Hu J, Yang H, Chen ZJ (2009) Spindle and chromosome changes of human MII oocytes during incubation after slow freezing/fast thawing procedures. Reprod Sci 16(4):391–396
Cobo A, Perez S, De los Santos MJ, Zulategui J, Domingo J, Remohi J (2008) Effect of different cryopreservation protocols on the metaphase II spindle in human oocytes. Reprod Biomed Online 17(3):350–359
Ciotti PM, Porcu E, Notarangelo L, Magrini O, Bazzocchi A, Venturoli S (2009) Meiotic spindle recovery is faster in vitrification of human oocytes compared to slow freezing. Fertil Steril 91(6):2399–2407
Coticchio G (2006) Sucrose concentration influences the rate of human oocytes with normal spindle and chromosome configurations after slow cooling cryopreservation. Hum Reprod 21:1771–1776
Rienzi L, Martinez F, Ubaldi F, Minasi MG, Iacobelli M, Tesarik J, Greco E (2004) Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 19(3):655–659
Noyes N, Knopman J, Labella P, McCaffrey C, Clark-Williams M, Grifo J (2010) Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril 94(6):2078–2082
Gook DA, Schiewe MC, Osborn SM, Asch RH, Jansen RP, Johnston WI (1995) Intracytoplasmic sperm injection and embryo development of human oocytes cryopreserved using 1,2-propanediol. Hum Reprod 10(10):2637–2641
Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443):1405–1410
Technologies SfA R (1996–2010) SartCors Online
Azim HA Jr., Peccatori FA, Pavlidis N (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: solid tumors. Cancer Treat Rev 36(2):101–109
Weisz B, Meirow D, Schiff E, Lishner M (2004) Impact and treatment of cancer during pregnancy. Exp Rev Anticancer Ther 4(5):889–902
Van Calsteren K, Vergote I, Amant F (2005) Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol 19(4):611–630
Method MW, Brost BC (1999) Management of cervical cancer in pregnancy. Semin Surg Oncol 16(3):251–260
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G (1991) Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol 9(11):1956–1961
Germann N, Haie-Meder C, Morice P, Lhomme C, Duvillard P, Hacene K, Gerbaulet A (2005) Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol 16(3):397–402
Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics, 2002. CA Cancer J Clin 52(1):23–47
American Cancer Society (2009–2010) Breast cancer facts & figures 2009–2010. American Cancer Society, Inc, Atlanta, GA
Moore HC, Foster RS Jr (2000) Breast cancer and pregnancy. Semin Oncol 27(6):646–653
Pavlidis N, Pentheroudakis G (2005) The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 31(6):439–447
Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98; discussion 9
Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15(9):1348–1351
Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN (1999) Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17(3):855–861
Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283–291
Azim HA Jr., Pavlidis N, Peccatori FA (2010) Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematol tumors. Cancer Treat Rev 36(2):110–121
Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2):126–140
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Silva, C., Chung, F.S. (2012). Pregnancy and Cancer. In: Quinn, G., Vadaparampil, S. (eds) Reproductive Health and Cancer in Adolescents and Young Adults. Advances in Experimental Medicine and Biology, vol 732. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2492-1_7
Download citation
DOI: https://doi.org/10.1007/978-94-007-2492-1_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2491-4
Online ISBN: 978-94-007-2492-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)